A review of dementia screening tools based on Mobile application
- PDF / 380,146 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 32 Downloads / 214 Views
REVIEW
A review of dementia screening tools based on Mobile application Fadi Thabtah 1 & David Peebles 2 & Jenny Retzler 2 & Chanchala Hathurusingha 1 Received: 16 February 2020 / Accepted: 7 April 2020 # IUPESM and Springer-Verlag GmbH Germany, part of Springer Nature 2020
Abstract Dementia is an umbrella term for multiple neurocognitive conditions that affect one’s functional independence making daily activities challenging. Early screening can be critical for successful management of the disease, thus tools implemented within mobile technology to speed up accessibility are becoming more common. This research critically analyses dementia and mild cognitive impartment (MCI) screening tools in terms of their clinical validity & acceptability, efficiency, and performance. We used inclusion and exclusion criteria to search Android and Apple mobile stores, for dementia and MCI screening applications. The comparison of the prevailing apps suggests that no app fulfils the considered evaluation criteria. Hence, the development of dementia screening apps that cover cognitive, memory, and execution domains defined within the neurocognitive disorders for dementia diagnosis of Statistical Manual of Mental Disorders (DSM-5), may provide clear clinical benefit as these domains are crucial. Apps such as Cognity are promising as they include new intelligent features by using artificial intelligence to screen individuals. Keywords Artificial intelligence . Dementia . Health technology . Medical screening . Medical informatics . Mobile application
1 Introduction Dementia is the descriptive term used to define difficulties pertaining to an individual’s memory, emotions, and cognitive and communication ability in performing normal day-to-day activities [1]. A number of neurological diseases are categorised under the umbrella of dementia, including Alzheimer’s disease (AD), Parkinson’s disease, and Huntington’s [2]. The number of Americans diagnosed with dementia was estimated at 5.8 million in 2019, and of those, 5.6 million were aged 65 years or above. It is also reported that these numbers continue to increase annually with a growth * Fadi Thabtah [email protected] David Peebles [email protected] Jenny Retzler [email protected] Chanchala Hathurusingha [email protected] 1
Digital Technologies, Manukau Institute of Technology, Manukau, Auckland, New Zealand
2
Department of Psychology, University of Huddersfield, Huddersfield HD1 3DH, UK
rate of 3% among Americans aged 65–74, 17% for people aged 75–84, and 32% for people aged above 85 [3]. Severe dementia can lead to profound consequences such as immobility and malnutrition, and eventually death. In 2019 there were 121,404 deaths from AD or other types of dementia reported in America [3]. Although the risk of dementia increases with age, it is not a normal part of getting old. To reduce the impact of the severe consequences associated with dementia, it is imperative to identify any symptoms as early as possible, to allow for appropriate monitoring
Data Loading...
